Abstract:Background & Aim MSCs are anchorage-dependent cells that require interaction with a substrate for cell survival and active proliferation. Achieving clinically relevant autologous cell doses in vitro requires significant surface area. Microcarriers are a commonly used, high surface area 3D culture solution combined with traditional bioreactors for allogeneic therapies; however, bioreactors are operated at a much larger scale than that required for personalized medicine. Therefore, a solution combining mid-size, fully closed, single use bags from Saint-Gobain's VueLife® product line with commercially available microcarriers is promising for autologous scale expansion of MSCs. As demonstrated here, VueLife® FEP bags are particularly attractive for this application due to the inherent non-stick properties of the FEP, preventing cell and microcarrier adhesion to the bag surface. Methods, Results & Conclusion For this study, human bone marrow-derived MSCs were purchased from RoosterBio Inc. and cultured in RoosterNourish™ MSC-XF medium. To assess donor-dependent variability in the cell culture performance, three individual donors were compared. MSC expansion was performed in Saint-Gobain's VueLife® 32-C bags with Corning® CellBIND® polystyrene microcarriers and Corning® Synthemax™ II-coated dissolvable microcarriers. Protocols for MSC attachment, expansion and harvest were developed for both microcarrier systems. Cell expansion results after 6 days of culture using the microcarriers are summarized in Tables 1+2. Strong donor-dependent variability was observed in the outcome, with expansion results ranging from 4- to 21-fold increase. However, because the CellBIND® beads are not transparent, cell attachment and harvest efficiency cannot be easily tracked by microscopy and may have also impacted the outcome. Cell attachment and expansion was easier to observe on the dissolvable microcarriers, with clear attachment after four hours and full confluence after four days of culture (Figure 1). MSCs showed 24-26-fold expansion for the three donors (Table 2) using the Corning® dissolvable microcarriers. MSC surface marker expression levels were not affected by culture on either microcarrier system in VueLife® bags and comparable to expression in T-175 flasks, as shown by flow cytometry. To support further expansion towards clinically-relevant doses, additional beads and media may be added to the bags. In , MSC expansion can be facilitated using microcarriers in VueLife® FEP bags for patient specific therapies. Results of MSC expansion on Corning's CellBIND® and Synthemax™ II-coated microcarriers after 6 days in culture in Saint-Gobain VueLife® 32-C bags. Results are shown for three tested MSC donors (#164, #172 and #227).

Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions

Successful Use of Human AB Serum to Support the Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cell in a Microcarrier-Based Platform

Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells

Biomanufacturing of Human Mesenchymal Stem Cells in Cell Therapy: Influence of Microenvironment on Scalable Expansion in Bioreactors

Influences of Xeno-Free Media on Mesenchymal Stem Cell Expansion for Clinical Application

Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells

E7-modified Gelatin Microcarriers for Efficient Expansion and Stemness Preservation of Mesenchymal Stem Cells

Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells

Scalable manufacture of therapeutic mesenchymal stromal cell products on customizable microcarriers in vertical wheel bioreactors that improve direct visualization, product harvest, and cost

Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools

Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium

Dual production of human mesenchymal stromal cells and derived extracellular vesicles in a dissolvable microcarrier-based stirred culture system

Mapping the microcarrier design pathway to modernise clinical mesenchymal stromal cell expansion

Derivation of Clinical -Grade Mesenchymal Stromal Cells from Umbilical Cord under Chemically De Fined Culture Condition-Platform for Future Clinical Application

Identification of critical process parameters for expansion of clinical grade human Wharton's jelly-derived mesenchymal stromal cells in stirred-tank bioreactors

From “bench to Bedside”: Current Advancement on Large-Scale Production of Mesenchymal Stem Cells

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell (MSC) Spheroids Primed in 3-D Cultures Under Xeno-free Conditions

3D MSC Culture in Saint-Gobain VueLife® FEP Bags Using Microcarriers

Ex vivo expansion of bone marrow mesenchymal stem cells using microcarrier beads in a stirred bioreactor

GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells

Generation and characterization of mesenchymal stromal cells for clinical application